Cargando…
Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies
BACKGROUND: Ovarian cancer causes more deaths than any other gynecological cancer. Identifying the molecular mechanisms that drive disease progress in ovarian cancer is a critical step in providing therapeutics, improving diagnostics, and affiliating clinical behavior with disease etiology. Identifi...
Autores principales: | Ben-Hamo, Rotem, Efroni, Sol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298526/ https://www.ncbi.nlm.nih.gov/pubmed/22236809 http://dx.doi.org/10.1186/1752-0509-6-3 |
Ejemplares similares
-
Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression
por: Ben-Hamo, Rotem, et al.
Publicado: (2011) -
Correction: Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression
por: Ben-Hamo, Rotem, et al.
Publicado: (2012) -
MicroRNA-Gene Association As a Prognostic Biomarker in Cancer Exposes Disease Mechanisms
por: Ben-Hamo, Rotem, et al.
Publicado: (2013) -
The whole-organism heavy chain B cell repertoire from Zebrafish self-organizes into distinct network features
por: Ben-Hamo, Rotem, et al.
Publicado: (2011) -
MicroRNA regulation of molecular pathways as a generic mechanism and as a core disease phenotype
por: Ben-Hamo, Rotem, et al.
Publicado: (2015)